Cargando…
Ex Vivo and In Vivo Regulation of Lipocalin-2, a Novel Adipokine, by Insulin
OBJECTIVE—Lipocalin-2, a novel adipokine, has been shown to be elevated in obese, insulin-resistant, and diabetic subjects. We therefore sought to study the ex vivo and in vivo effects of insulin on lipocalin-2 levels in humans. RESEARCH DESIGN AND METHODS—We investigated the in vivo effects of insu...
Autores principales: | Tan, Bee K., Adya, Raghu, Shan, Xiaoye, Syed, Farhatullah, Lewandowski, Krzysztof C., O'Hare, John P., Randeva, Harpal S. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2606846/ https://www.ncbi.nlm.nih.gov/pubmed/18852336 http://dx.doi.org/10.2337/dc08-1236 |
Ejemplares similares
-
Insulin and Metformin Regulate Circulating and Adipose Tissue Chemerin
por: Tan, Bee K., et al.
Publicado: (2009) -
Serum Levels of the Adipokine FGF21 Depend on Renal Function
por: Stein, Sebastian, et al.
Publicado: (2009) -
Ghrelin attenuates inflammation in diabetic lung disease by TLR4 pathway in vivo and in vitro
por: Liu, Xiao-Yan, et al.
Publicado: (2023) -
In Vivo Insulin Sensitivity and Secretion in Obese Youth: What are the differences between normal glucose tolerance, impaired glucose tolerance, and type 2 diabetes?
por: Bacha, Fida, et al.
Publicado: (2009) -
Using in vivo corneal confocal microscopy to identify diabetic sensorimotor polyneuropathy risk profiles in patients with type 1 diabetes
por: Lewis, Evan J H, et al.
Publicado: (2017)